EXACT SCIENCES CORP Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 23 rows in 2017. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2017-12-22: Reporting owner Conroy Kevin T; Form 4; Security Stock Option (right to buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2017-12-06: Reporting owner Conroy Kevin T; Form 4; Security Stock Option (right to buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2017-11-21: Reporting owner Conroy Kevin T; Form 4; Security Stock Option (right to buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2017-11-09: Reporting owner Conroy Kevin T; Form 4; Security Stock Option (right to buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2017-12-22 | Conroy Kevin T Director, Officer (President and CEO) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −123,512 500,843 owned after | $0.83 exercise price | 2017-12-26 | |
| 2017-12-06 | Conroy Kevin T Director, Officer (President and CEO) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −121,849 624,355 owned after | $0.83 exercise price | 2017-12-08 | |
| 2017-11-21 | Conroy Kevin T Director, Officer (President and CEO) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −134,057 746,204 owned after | $0.83 exercise price | 2017-11-22 | |
| 2017-11-09 | Conroy Kevin T Director, Officer (President and CEO) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −137,815 880,261 owned after | $0.83 exercise price | 2017-11-13 | |
| 2017-10-26 | Casdin Eli Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,100 10,100 owned after | $49.33 exercise price | 2017-10-30 | |
| 2017-10-02 | LIDGARD GRAHAM PETER Officer (Chief Science Officer) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −35,250 11,750 owned after | $13.96 | 2017-10-03 | |
| 2017-09-06 | LIDGARD GRAHAM PETER Officer (Chief Science Officer) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −33,075 0 owned after | $9.07 exercise price | 2017-09-07 | |
| 2017-09-06 | LIDGARD GRAHAM PETER Officer (Chief Science Officer) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −9,242 0 owned after | $10.82 exercise price | 2017-09-07 | |
| 2017-09-05 | LIDGARD GRAHAM PETER Officer (Chief Science Officer) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −19,425 33,075 owned after | $9.07 exercise price | 2017-09-07 | |
| 2017-09-05 | LIDGARD GRAHAM PETER Officer (Chief Science Officer) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −30,258 9,242 owned after | $10.82 exercise price | 2017-09-07 | |
| 2017-09-05 | LIDGARD GRAHAM PETER Officer (Chief Science Officer) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −12,250 12,250 owned after | $23.38 exercise price | 2017-09-07 | |
| 2017-09-05 | LIDGARD GRAHAM PETER Officer (Chief Science Officer) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −13,750 41,250 owned after | $5.70 exercise price | 2017-09-07 | |
| 2017-08-28 | THOMPSON DAVID Director | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −19,168 0 owned after | $3.43 exercise price | 2017-08-30 | |
| 2017-08-28 | THOMPSON DAVID Director | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −7,667 0 owned after | $3.43 exercise price | 2017-08-30 | |
| 2017-08-28 | THOMPSON DAVID Director | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −15,772 0 owned after | $8.52 exercise price | 2017-08-30 | |
| 2017-08-28 | THOMPSON DAVID Director | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,257 0 owned after | $8.52 exercise price | 2017-08-30 | |
| 2017-08-28 | THOMPSON DAVID Director | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −4,608 0 owned after | $10.18 exercise price | 2017-08-30 | |
| 2017-08-17 | Conroy Kevin T Director, Officer (President and CEO) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −9,242 96,758 owned after | $10.82 exercise price | 2017-08-17 | |
| 2017-07-27 | LIDGARD GRAHAM PETER Officer (Chief Science Officer) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +81,000 81,000 owned after | $21.68 exercise price | 2017-07-28 | |
| 2017-07-27 | Elliott Jeffrey Thomas Officer (Chief Financial Officer) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +65,000 65,000 owned after | $21.68 exercise price | 2017-07-28 | |
| 2017-07-27 | COWARD D SCOTT Officer (SVP and General Counsel) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +75,000 75,000 owned after | $21.68 exercise price | 2017-07-28 | |
| 2017-07-27 | Conroy Kevin T Director, Officer (President and CEO) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +240,000 240,000 owned after | $21.68 exercise price | 2017-07-28 | |
| 2017-07-27 | ARORA MANEESH Director, Officer (COO) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +132,000 132,000 owned after | $21.68 exercise price | 2017-07-28 |